Romeo G, Devoto M, Galietta L J
Laboratorio di Genetica Molecolare, Istituto G. Gaslini, Genova, Italy.
Hum Genet. 1989 Dec;84(1):1-5. doi: 10.1007/BF00210660.
The high incidence of cystic fibrosis (CF) in most European populations (and populations of European descent) can be explained by different hypotheses that can be tested using the available data concerning this disorder. Among the five hypotheses discussed (genetic heterogeneity, high rate of mutation, meiotic drive, drift and heterozygote advantage), only the last is supported by experimental data. The following conclusions can be drawn from the evidence that we have reviewed: (1) CF is a single gene disorder (genetically homogeneous). (2) Haplotypes associated with the CF gene suggest that only a few mutations (the same gene located in 7q13 is always affected) are responsible for the disorder. (3) CF with pancreatic insufficiency is mainly associated with a single haplotype, whereas CF with pancreatic sufficiency is more frequently associated with different haplotypes. (4) A selective advantage consisting of higher resistance to Cl- -secreting diarrhoeas might have favored, in the past, survival of infants heterozygous for the CF gene.
在大多数欧洲人群(以及欧洲裔人群)中,囊性纤维化(CF)的高发病率可以通过不同假说加以解释,这些假说可利用有关该疾病的现有数据进行检验。在讨论的五个假说(基因异质性、高突变率、减数分裂驱动、遗传漂变和杂合子优势)中,只有最后一个得到了实验数据的支持。从我们所回顾的证据中可以得出以下结论:(1)CF是一种单基因疾病(基因同质)。(2)与CF基因相关的单倍型表明,只有少数突变(位于7q13的同一个基因总是受到影响)导致该疾病。(3)伴有胰腺功能不全的CF主要与单一单倍型相关,而伴有胰腺功能正常的CF更常与不同单倍型相关。(4)过去,对分泌氯离子腹泻具有更高抵抗力所带来的选择性优势,可能有利于CF基因杂合子婴儿的存活。